Literature DB >> 20362675

Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements.

Mehul P Sampat1, Brian C Healy, Dominik S Meier, Elisa Dell'Oglio, Maria Liguori, Charles R G Guttmann.   

Abstract

The measurement of brain atrophy from magnetic resonance imaging (MRI) has become an established method of estimating disease severity and progression in multiple sclerosis (MS). Most commonly reported in the form of brain parenchymal fraction (BPF), it is more sensitive to the degenerative component of the disease and shows progression more reliably than lesion burden. Typically, the reliability of BPF and other morphometric measurements is assessed by evaluating scan-rescan experiments. While these experiments provide good estimates of real-life error related to imperfect patient repositioning in the MRI scanner, measurement variance due to physiological and reversible pathological fluctuations in brain volume are not taken into account. In this work, we propose a new model for estimating variability in serial morphometry, particularly the BPF measurement. Specifically, we attempt to detect and explicitly model the remaining sources of error to more accurately describe the overall variability in BPF measurements. Our results show that sources of variability beyond subject repositioning error are important and cannot be ignored. We demonstrate that scan-rescan experiments only provide a lower bound on the true error in repeated measurements of patients' BPF. We have estimated the variance due to patient repositioning during scan-rescan (sigma(sr)(2) = 3.0e-06), variance assigned to physiological fluctuations (sigma(p)(2) = 5.74e-06) and the variance associated with lesion activity (sigma(les)(2) = 1.09e-05). These variance components can be used to determine the relative impact of their sources on sample size estimates for studies investigating change over time in MS patients. Our results demonstrate that sample size calculations based exclusively on scan-rescan variability (sigma(sr)) are likely to underestimate the number of patients required. If the physiological variability (sigma(p)) is incorporated in sample size calculations, the required sample size would increase by a factor of 5.69 based on standard t-test sample size calculation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20362675     DOI: 10.1016/j.neuroimage.2010.03.075

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  14 in total

Review 1.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques.

Authors:  F Durand-Dubief; B Belaroussi; J P Armspach; M Dufour; S Roggerone; S Vukusic; S Hannoun; D Sappey-Marinier; C Confavreux; F Cotton
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

3.  SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.

Authors:  Marco Battaglini; Mark Jenkinson; Nicola De Stefano
Journal:  Hum Brain Mapp       Date:  2017-12-08       Impact factor: 5.038

Review 4.  Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.

Authors:  François De Guio; Eric Jouvent; Geert Jan Biessels; Sandra E Black; Carol Brayne; Christopher Chen; Charlotte Cordonnier; Frank-Eric De Leeuw; Martin Dichgans; Fergus Doubal; Marco Duering; Carole Dufouil; Emrah Duzel; Franz Fazekas; Vladimir Hachinski; M Arfan Ikram; Jennifer Linn; Paul M Matthews; Bernard Mazoyer; Vincent Mok; Bo Norrving; John T O'Brien; Leonardo Pantoni; Stefan Ropele; Perminder Sachdev; Reinhold Schmidt; Sudha Seshadri; Eric E Smith; Luciano A Sposato; Blossom Stephan; Richard H Swartz; Christophe Tzourio; Mark van Buchem; Aad van der Lugt; Robert van Oostenbrugge; Meike W Vernooij; Anand Viswanathan; David Werring; Frank Wollenweber; Joanna M Wardlaw; Hugues Chabriat
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-11       Impact factor: 6.200

5.  Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis.

Authors:  R T Shinohara; J Oh; G Nair; P A Calabresi; C Davatzikos; J Doshi; R G Henry; G Kim; K A Linn; N Papinutto; D Pelletier; D L Pham; D S Reich; W Rooney; S Roy; W Stern; S Tummala; F Yousuf; A Zhu; N L Sicotte; R Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-22       Impact factor: 3.825

6.  Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling.

Authors:  Blake C Jones; Govind Nair; Colin D Shea; Ciprian M Crainiceanu; Irene C M Cortese; Daniel S Reich
Journal:  Neuroimage Clin       Date:  2013-08-13       Impact factor: 4.881

7.  Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: implications for monitoring atrophy in clinical studies.

Authors:  Kunio Nakamura; Robert A Brown; David Araujo; Sridar Narayanan; Douglas L Arnold
Journal:  Neuroimage Clin       Date:  2014-08-23       Impact factor: 4.881

Review 8.  Imaging outcome measures for progressive multiple sclerosis trials.

Authors:  Marcello Moccia; Nicola de Stefano; Frederik Barkhof
Journal:  Mult Scler       Date:  2017-10       Impact factor: 6.312

9.  Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.

Authors:  Rebecca Spain; Katherine Powers; Charles Murchison; Elizabeth Heriza; Kimberly Winges; Vijayshree Yadav; Michelle Cameron; Ed Kim; Fay Horak; Jack Simon; Dennis Bourdette
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-06-28

10.  Modeling disease severity in multiple sclerosis using electronic health records.

Authors:  Zongqi Xia; Elizabeth Secor; Lori B Chibnik; Riley M Bove; Suchun Cheng; Tanuja Chitnis; Andrew Cagan; Vivian S Gainer; Pei J Chen; Katherine P Liao; Stanley Y Shaw; Ashwin N Ananthakrishnan; Peter Szolovits; Howard L Weiner; Elizabeth W Karlson; Shawn N Murphy; Guergana K Savova; Tianxi Cai; Susanne E Churchill; Robert M Plenge; Isaac S Kohane; Philip L De Jager
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.